Dr. Reddy’s, Alvotech to co-develop, market biosimilar of Merck’s cancer drug Keytruda
Dr. Reddy’s headquarters in Hyderabad | Photo Credit: Arrangement Pharma main Dr. Reddy’s Laboratories and Nasdaq-listed international biotech agency Alvotech will co-develop, manufacture and commercialise a biosimilar candidate to Merck’s
